Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abaloparatide for Pelvic Fracture Healing
NCT04249232Phase 2Completed
- Sponsor
- Hospital for Special Surgery
- Start
- Sep 2020
- Primary completion
- Apr 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of abaloparatide in pelvic fracture, sponsored by Hospital for Special Surgery. Started Sep 2020; status: completed.
02
Drugs
abaloparatide
03
Conditions
pelvic fracture
Beyond the preview
Go deeper on NCT04249232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04249232.